[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
Choné
L
L
Fléjou
J F
JF
Grignon
Y
Y
Bigard
M A
MA
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000208:Acute Disease; D000658:Amoxicillin / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005756:Gastritis / Q000188:drug therapy / Q000382:microbiology*; D016998:Helicobacter / Q000302:isolation & purification*; D016481:Helicobacter Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000188:drug therapy / Q000382:microbiology*; D014011:Tinidazole / Q000627:therapeutic use
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D010406:Penicillins; D014011:Tinidazole; D064747:Lansoprazole; D000658:Amoxicillin; D009853:Omeprazole
Helicobacter heilmannii: nouveau germe spiralé pouvant être responsable de gastrites ulcérées.